Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin-Reference-Cited by-同舟云学术

Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin

Published:1996-06 Issue:1 Volume:34 Page:95-96
ISSN:1011-1344
Container-title:Journal of Photochemistry and Photobiology B: Biology
language:en
Short-container-title:Journal of Photochemistry and Photobiology B: Biology

Author:

Peng Qian,Moan Johan,Warloe Trond,Iani Vladimir,Steen Harald B.,Bjørseth Alf,Nesland Jahn M.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Biophysics,Radiological and Ultrasound Technology,Radiation

Reference8 articles.

1. Photodynamic therapy with endogenous protoporphyrin IX: basic principle and present clinical experience;Kennedy;J. Photochem. Photobiol. B: Biol.,1990

2. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma;Peng;Int. J. Cancer,1992

3. Fluorescence distribution and photodynamic effect of ALA-induced PpIX in the DMH rat colonic tumor model;Bedwell;Br. J. Cancer,1992

4. Oral vs i.v. administration of 5-ALA;Loh;Br. J. Cancer,1993

5. Photodynamic therapy with 5-aminolevulinic acid induced porphyrins and DMSO/EDTA for basal cell carcinoma;Warloe;Soc. Photo-Opt. Instrum. Eng.,1995

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highways and Detours in the Realm of Photodynamic Therapy;International Journal of Molecular Sciences;2024-03-08

2. Advances in 5-aminoketovaleric acid(5-ALA) nanoparticle delivery system based on cancer photodynamic therapy;Journal of Drug Delivery Science and Technology;2022-12

3. Gadolinium-Doped Iron Nanostructures Decorated with Novel Drugs for Magnetic Resonance Imaging, Photodynamic, and Photothermal Therapy Applications;Magnetic Nanoheterostructures;2020

4. Long-term efficacy data for daylight-PDT;Giornale Italiano di Dermatologia e Venereologia;2018-12

5. Current developments in pharmacotherapy for actinic keratosis;Expert Opinion on Pharmacotherapy;2018-10-09